Document ID: chunk:federal_register_of_legislation:F2020C00213:body:0:p6
Version: federal_register_of_legislation:F2020C00213
Segment Type: other
Provision Reference: 
Character Range: 14024–17354

exposure to high levels of volatile polycyclic aromatic hydrocarbons:
            (i)            for a cumulative period of at least 1 500 hours before the clinical onset of malignant neoplasm of the lung; and
            (ii)         where the first inhalation of fumes occurred at least five years  before the clinical onset of malignant neoplasm of the lung; or

         (bb)           inhaling fumes generated during iron and steel founding or in rubber production, while in an enclosed space in immediate proximity to production facilities:
            (i)            for a cumulative period of at least 1 500 hours before the clinical onset of malignant neoplasm of the lung; and
            (ii)         where the first inhalation of fumes occurred at least five years before the clinical onset of malignant neoplasm of the lung; or

         (cc)            receiving MOPP at least five years before the clinical onset of malignant neoplasm of the lung; or

         (dd)           in current smokers only, receiving 20 milligrams of beta-carotene supplement daily for a continuous period of at least three years, before the clinical onset of malignant neoplasm of the lung; or

         (ee)            being infected with human immunodeficiency virus before the clinical onset of malignant neoplasm of the lung; or

         (ff)              having scleroderma at least three years before the clinical onset of malignant neoplasm of the lung; or

         (gg)           inability to obtain appropriate clinical management for malignant neoplasm of the lung.

Factors that apply only to material contribution or aggravation

    7. Paragraph 6(gg) applies only to material contribution to, or aggravation of, malignant neoplasm of the lung where the person's malignant neoplasm of the lung was suffered or contracted before or during (but not arising out of) the person's relevant service.

Inclusion of Statements of Principles

    8. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.

Other definitions

9. For the purposes of this Statement of Principles:

    "a chemical substance from the specified list" means:
        (a)          coal tar pitch or concentrated coal tar distillates;
        (b)         creosote; or
        (c)          molten bitumen during roofing and mastic-asphalt work;

    "a metal or metalloid from the specified list" means:
        (a)          arsenic and inorganic arsenic compounds;
        (b)          beryllium and beryllium compounds;
        (c)          cadmium and cadmium compounds;
        (d)          cobalt metal with tungsten carbide;
        (e)          hexavalent chromium (chromium VI) compounds; or
        (f)           mixtures that include nickel metal and nickel compounds;

    "a pulmonary disease from the specified list" means:
        (a)          bacterial pneumonia;
        (b)          chronic obstructive pulmonary disease; or
        (c)          pulmonary tuberculosis;

    "a specified industry or manufacturing process" means:
        (a)        aluminium production;